Search
for
Sort by
Research 661–690 of 1000+
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- COVID-19 and hypopituitarism
- Cross-section Trichometry: A Clinical Tool for Assessing the Progression and Treatment Response of Alopecia
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- COVID-19 pandemic: what about the gonads?
- A machine learning and network framework to discover new indications for small molecules
- Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients after Finasteride Treatment for a Year
- Metabolism and skin diseases
- Clinical and genetic findings in a Chinese family with VDR-associated hereditary vitamin D-resistant rickets
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Ashwagandha root in the treatment of non-classical adrenal hyperplasia
- Physiology of Testicular Function
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Systemic Lupus Erythematosus Presenting as Alopecia Areata
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- A Study on the Clinical and Hormonal Profile of Polycystic Ovarian Syndrome Patients Attending a Tertiary Care Hospital: A Descriptive Cross-sectional Study
- Ovarian vein sampling, and serum and urine testosterone monitoring in ovarian Leydig cell tumors: A report of two cases
- Telogen hair loss
- HAIRY PREGNANCY
- A Large Benign Adrenocortical Adenoma Cosecreting Testosterone and Cortisol
- Short-Term Clinical Assessment of Treating Female Androgenic Alopecia with Autologous Stem Cells Derived from Human Hair Follicles
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome